Catalyst Wire Dossier Catalyst Wire Dossier

Descovy

emtricitabine/tenofovir alafenamide · Gilead Sciences
Drug timelines are a Plus or Pro feature.

21 regulatory and trial events tracked for Descovy, covering 2016-04-04 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV [Phase 2, Phase 3]

See pricing